Profiel
Stephen Goodall is the founder of Firebrick Pharma Ltd., which is founded in 2012, where he holds the title of Chief Operating Officer & Director.
He was also a Director-Pharmaceutical Development at Vapotronics, Inc. from 1999 to 2001 and the Chief Operating Officer at Viralytics Pty Ltd.
from 2008 to 2011.
Actieve functies van Stephen Goodall
| Bedrijven | Functie | Begin |
|---|---|---|
| FIREBRICK PHARMA LIMITED | Oprichter | 12-04-2012 |
Eerdere bekende functies van Stephen Goodall
| Bedrijven | Functie | Einde |
|---|---|---|
| VIRALYTICS LTD. | Operationeel Directeur | 31-08-2011 |
Vapotronics, Inc.
 Vapotronics, Inc. Medical SpecialtiesHealth Technology Vapotronics, Inc. develops inhalation drug products. The company is headquartered in South Brisbane, Australia. | Corporate Officer/Principal | 01-06-2001 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| FIREBRICK PHARMA LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
Vapotronics, Inc.
Vapotronics, Inc. Medical SpecialtiesHealth Technology Vapotronics, Inc. develops inhalation drug products. The company is headquartered in South Brisbane, Australia. | Health Technology |
